Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
Oriana Miltiadous(Icahn School of Medicine at Mount Sinai), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Charissa Chang(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Kate Revill(Emory University), Jorge Rakela(University of Pittsburgh), Daniela Sia(Icahn School of Medicine at Mount Sinai), Maria Isabel Fiel(Icahn School of Medicine at Mount Sinai), Poh Seng Tan(National University Health System), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Hui Dong(Second Military Medical University), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Andrew Harrington(Icahn School of Medicine at Mount Sinai), Thomas Byrne(WinnMed), Sander Florman(Mount Sinai Hospital), Sasan Roayaie(White Plains Hospital), Yujin Hoshida(Broad Institute)
Cited by 84
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k